Women's Health Reading List

For articles from MD Consult, we can only provide a link to the journal in MD Consult (not directly to the article). Users will need to search for the article within the MD Consult database. Please see relevant articles in the reading lists for further instructions.

Material from UpToDate can only be accessed in NMH, NU Chicago, or NU Evanston buildings. Remote access is not permitted.

Concerning Copyright Restrictions

The Copyright law of the United States (Title 17, United States Code) governs the making of photocopies or other reproductions of copyright material. Under certain conditions specified in the law, libraries and archives are authorized to furnish a photocopy or other reproduction, which is not to be "used for any purposes other than private study, scholarship or research." If a user makes a request for, or later uses, a photocopy or reproduction for purposes in excess of "fair use", that user may be liable for copyright infringement.

Breast Disease

Elmore JG, Armstrong K, Lehman CD, Fletcher SW.
Screening for Breast Cancer. JAMA. 2005 Mar 9;293(10):1245-56.

Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002 Sep 3;137(5 Part 1):347-60.

U.S. Preventive Services Task Force. Screening for Breast Cancer: Recommendations and Rationale. Ann Intern Med. 2002 Sep 3;137(5 Part 1):344-6.

Benign Breast Disease. Priyanath A, Didwania A, Dolan N, Clare, SE. Atlas of Office Procedures, Volume 4(3), September 2001.

Fisher B et al. Tamoxifen for Prevention of Breast Cancer. J Natl Cancer Inst 1998; 90(18): 1371-88.

Armstrong K. Eisen A. Weber B. Assessing the risk of breast cancer. N Engl J Med. 342(8): 564 -71, 2000 Feb 24.

Gail MH. Costantino JP. Bryant J. Croyle R. Freedman L. Helzlsouer K. Vogel V. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst. 91(21): 1829-46, 1999 Nov 3.

Elmore JG. Barton MB. Moceri VM. Polk S. Arena PJ. Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 338(16):1089-96, 1998 Apr 16.

Thomas DB. Gao DL. Self SG. Allison CJ. Tao Y. Mahloch J. Ray R. Qin Q. Presley R. Porter P. Randomized trial of breast self-examination in Shanghai: methodology and preliminary results. J Natl Cancer Inst. 89(5):355-65, 1997 Mar 5.

Barton MB. Harris R. Fletcher SW. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA. 282(13):1270-80, 1999 Oct 6.

Chlebowski R. T. Reducing the risk of breast cancer. N Engl J Med. 2000 Jul 20;343(3):191-8.

Burstein H. J., Winer E. P. Primary Care: Primary Care for Survivors of Breast Cancer. N Engl J Med. 2000 Oct 12;343(15):1086-94.

Return to top

Cardiology

Ridker PM, M.D., Cook NR, Lee IM,., Gordon D, Gaziano M, Manson JE, et al. A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women. New Engl J Med. 2005; 352:1293-1304.

Mieres JH; Shaw LJ; Arai A; Budoff MJ; Flamm SD; Hundley WG, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 2005;111(5):682-96.

Mosca L,. Appel LA, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, et al. Evidence-Based Guide for Cardiovascular Disease Prevention in Women. Circulation. 2004: 109; 672-693.

Johnson BD, Shaw LJ, Buchthal SD, Merz CNB, Kim HW, Scott KN, et al. Prognosis in Women With Myocardial Ischemia in the Absence of Obstructive Coronary Disease Results From the National Institutes of Health–National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109:2993-2999.

Hulley S; Grady D; Bush T; Furberg C; Herrington D; Riggs B; Vittinghoff E. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;19;280(7):605-13.

Return to top

Osteoporosis

Raisz LG. Screening for Osteoporosis. N Engl J Med. 2005; 353 (2)164-171.

Cummings, SR, Bates, D, Black, DM. Clinical use of bone densitometry: scientific review. JAMA 2002; 288:1889.

Black D. M., Greenspan S. L., Ensrud K. E., Palermo L., McGowan J. A., Lang T. F., Garnero P., Bouxsein M. L., Bilezikian J. P., Rosen C. J., the PaTH Study Investigators. The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis. N Engl J Med. 2003; 349:1207-1215.

Neer RM. Arnaud CD. Zanchetta JR. Prince R. Gaich GA. Reginster JY. Hodsman AB. Eriksen EF. Ish-Shalom S. Genant HK. Wang O. Mitlak BH. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001. 344(19):1434-41.

NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. Osteoporosis Prevention, Diagnosis, and Therapy. JAMA 2001; 285(6): 785-95.

Harris ST. Watts NB. Genant HK. McKeever CD. Hangartner T. Keller M. Chesnut CH 3rd. Brown J. Eriksen EF. Hoseyni MS. Axelrod DW. Miller PD. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 1999. 282(14):1344-52.

Ettinger B. et al. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 1999. 282(7):637-45.

Cummings SR, Black DM, Thompson DE, ; Applegate WB; Barrett-Connor E; Musliner TA,et al. Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures: Results From the Fracture Intervention Trial. JAMA.1998; 280: 2077-2082.

National Osteoporosis Foundation. Physician's Guide to Prevention and Treatment of Osteoporosis. (Accessed 3/7/05 ).

Return to top

Endocrinology

PCOS

Ehrmann D. A. Polycystic Ovarian Syndrome. N Engl J Med. 2005; 352:1223-1236.

Infertility

Lobo RA. Options for Preservation of Fertility in Women. N Engl J Med. 2005; 353:64-73.

Smith S; Pfeifer SM; Collins JA. Diagnosis and Management of Female Infertility. JAMA, Oct 2003; 290: 1767-1770.

Hirsutism

Rittmaster RS. Hirsutism. Lancet. 349(9046):191-5, 1997 Jan 18.

Prolactinoma

Schlechte J. A. Prolactinoma. N Engl J Med. 2003 Nov 20;349(21):2035-41. Thyroid Disease

Mulder, JE. Thyroid disease in women. Med Clin North Am 1998; 82(1): 103-25. (No direct link to article available. Click on link above, enter "mulder" in the author field on the left of the screen and click Search.)

Return to top

Gynecology

Vaginitis

Sobel JD. Vaginitis. N Engl J Med 1997. 337(26):1896-903.

Sobel JD, Wiesenfeld HC, Martens M., Danna P, Hooton T.M, Rompalo A., et al. Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis. N Engl J Med.2004; 351:876-883

STDs

Miller KE. Sexually Transmitted Diseases. Prim Care Clin Office Practice 1997. 24(1): 179-93. (No direct link to article available. Click on link above, enter "miller" in the author field on the left of the screen and click Search.)

Scholes D. Stergachis A. Heidrich FE. Andrilla H. Holmes KK. Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 334(21):1362-6, 1996 May 23.

U.S. Preventive Services Task Force. Screening for Chlamydial Infection. 2001. http://www.ahrq.gov/clinic/uspstf/uspschlm.htm

U.S. Preventive Services Task Force. Screening for Gonorrhea. 2005. http://www.ahrq.gov/clinic/uspstf/uspsgono.htm

Return to top

Urogynecology

Jayna M. Holroyd-Leduc; Sharon E. Straus. Management of Urinary Incontinencein Women: Scientific Review.
JAMA, February 25, 2004 ; 291: 986-995.

Jayna M. Holroyd-Leduc; Sharon E. Straus. Management of Urinary Incontinence in Women: Clinical Applications. JAMA, February 25, 2004 ; 291: 996-999.

Fihn S. D. Acute Uncomplicated Urinary Tract Infection in Women. N Engl J Med 2003; 349:259-266.

Contraception

Westhoff C. Emergency Contraception. N Engl J Med. 2004; 349:1830-1835.

Stewart FH, Harper CC, Ellertson CE; Grimes DA,. Sawaya GF, Trussell J. Clinical Breast and Pelvic Examination Requirements for Hormonal Contraception: Current Practice vs Evidence. JAMA, May 2001; 285: 2232 - 2239.

Petitti, D. B. Combination Estrogen-Progestin Oral Contraceptives. N Engl J Med . 2003; 349: 1443-1450.

Return to top

Cervical Cancer Screening

Cervical Cancer: ACS Cancer Detection Guidelines. American Cancer Society, Inc. Atlanta, 2005 http://www.cancer.org

U.S. Preventive Services Task Force: Screening for Cervical Cancer: Guide to Clinical Preventive Services. AHRQ Publication No. 03-515A, Agency for Healthcare Research and Quality, Rockville, Maryland, 2003 http://www.ahrq.gov/clinic/uspstf/uspscerv.htm

Solomon, D, Davey, D, Kurman, R, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 2002; 287:2114.

Wright, TC, Cox, JT, Massad, LS, et al. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287:2120.

Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003 Jun;188(6):1383-92.

Solomon D. Schiffman M. Tarone R. ALTS Study group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 93(4):293-9, 2001 Feb 21.

Sawaya GF. Grady D. Kerlikowske K. Valleur JL. Barnabei VM. Bass K. Snyder TE. Pickar JH. Agarwal SK. Mandelblatt J. The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS). Ann Intern Med. 133(12):942-50, 2000 Dec 19.

Return to top

Menopause

National Institutes of Health State-of-the-Science Conference Statement: Management of Menopause-Related Symptoms. Ann Intern Med. Jun 2005; 142: 1003-1013.

Nelson HD. Commonly Used Types of Postmenopausal Estrogen for Treatment of Hot Flashes: Scientific Review. JAMA. 2004; 291: 1610-1620.

Bastian LA, Smith CM; Nanda K. Is This Woman Perimenopausal? JAMA, Feb 2003; 289: 895 - 902.

U.S. Preventive Services Task Force.Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Women: Recommendations from the U.S. Preventive Services Task Force. Ann Intern Med, May 2005; 142: 855-860.

Obstetrics

Mason E, Rosene-Montella K, Powrie R. Medical Problems during Pregnancy. Med Clin North Am 1998; 82(2): 249-69. (No direct link to article available. Click on link above, enter "mason" in the author field on the left of the screen and click Search.)

Ito S. Drug therapy for breast-feeding women. N Engl J Med. 343(2):118-26, 2000 Jul 13.

Thacker HL. Medical Aspects of Pregnancy. J Womens Health. 1999;335-46.

Return to top

Behavioral/Psychiatric Medicine

Depression

Altshuler LL. Cohen LS. Moline ML. Kahn DA. Carpenter D. Docherty JP. The Expert Consensus Panel for Depression in Women. The Expert Consensus Guideline Series. Treatment of depression in women. Postgrad Med. (Spec No):1-107, 2001 Mar.

Domestic Violence

Eisenstat SA. Bancroft L. Domestic violence. N Engl J Med. 341(12):886-92, 1999 Sep 16.

Eating Disorders

Walsh JME, Wheat ME, Freund K. Detection, Evaluation, and Treatment of Eating Disorders:The Role of the Primary Care Physician. J Gen Intern Med. 2000 Aug;15(8):577-90.

Becker AE, Grinspoon SK, Klibanski A, Herzog DB. Eating Disorders. N Engl J Med 1999. 340(14): 1092-98.

Return to top

Selected Women's Health Initiative (WHI) Publications

Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Kooperberg C; Stefanick ML;,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288(3):321-33.

Anderson GI, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, et al.; Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004 Apr 14;291(14):1701-12.

Shumaker S, Legault C, Kuller L, Rapp S, Thal L, Lane D, Fillit H, Stefanick M, Hendrix S, Lewis CB, Masaki K, Coker L. Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women. JAMA 2004;291:2947-2958.

Shumaker S, Legault C, Thal L, Wallace R, Ockene J, Hendrix S, Jones III B, Assaf A, Jackson R, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J. Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial. JAMA 2003;289:2651-2662.

Rapp S, Espeland M, Shumaker S, Henderson V, Brunner R, Manson J, Gass M, Stefanick M, Lane D, Hays J, Johnson K, Coker L, Dailey M, Bowen D. Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial. JAMA 2003;289:2663-2672.

Espeland M, Rapp S, Shumaker S, Brunner R, Manson J, Sherwin B, Hsia J, Margolis K, Hogan P, Wallace R, Dailey M, Freeman R, Hays J. Conjugated Equine Estrogens and Global Cognitive Function in Postmenopausal Women. JAMA 2004;291:2959-2968.

For complete listing:
http://www.nhlbi.nih.gov/whi/references.htm

Web Resources

Journal Watch Women’s Health
http://womens-health.jwatch.org/
Medscape Women’s Health
http://www.medscape.com/womenshealthhome
National Women’s Health Information Center
http://www.4woman.gov

Return to top